Immunological Aspects of Macular Edema after Cataract Surgery in Patients with Diabetes Mellitus

Cytokines are polypeptides which are produced by a broad range of cells of the body. They play a key role in the formation and regulation of protective reactions. The researchers attempt to find predictors for the development of exudative-inflammatory reaction after surgery. It led to study of the eyes immunological status. It is known that a change of the pro- and anti-inflammatory cytokines balance leads to the blood-ocular barrier dysfunction that increases the inflammatory reaction. It is interesting the blood-ocular barrier has already damaged in diabetic patients. The paper examines the epidemiology, pathogenesis and possible methods of prevention the postoperative cystoid macular edema, presents investigations describing the change in the local cytokine status in patients with diabetes and the association between cytokines concentrations and the severity of diabetic retinopathy. The manuscript has shown possibilities of multiplex analysis, emphasized the features of individual cytokines and angiogenic factors, highlighted cytokines as predictors of macular edema after cataract surgery. The study of the cytokines role in the development of ophthalmic pathology led to the creation the new pathogenetically oriented eye diseases therapy. Further studies of the cytokine status in patients with macular edema after phacoemulsification are needed to determine the possible treatment methods.

1. Bourne R., Flaxman S.R., Braithwaite T., Cicinelli M.V., Das A., Jonas J.B. Vision Loss Expert Group. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(9):e888–897.

2. Дедов И.И., Шестакова М.В., Сунцов Ю.И., Петеркова В.А., Галстян Г.Р., Майоров А.Ю., Кураева Т.Л., Сухарева О.Ю. Результаты реализации подпрограммы «Сахарный диабет» Федеральной целевой программы «Предупреждение и борьба с социально значимыми заболеваниями 2007–2012 годы». Сахарный диабет. 2013;16(2S):2–48 [Dedov I.I., Shestakova M.V., Suntsov Yu.I., Peterkova V.A., Galstjan G.R., Majorov A.Yu., Kuraeva T.L., Suhareva O.Yu. Federal targeted programme “Prevention and Management of Socially Significant Diseases (2007– 2012)”: results of the “Diabetes mellitus” sub-programme. Diabetes mellitus = Saharnyj diabet. 2013;16(2S):2–48 (In Russ.)]. DOI: 10.14341/2072-0351-3879

3. Липатов Д.В., Александрова В.К., Атарщиков Д.С., Бессмертная Е.Г., Кон И.Л., Кузьмин А.Г., Смирнова Н.Б., Толкачева А.А., Чистяков Т.А. Эпидемиология и регистр диабетической ретинопатии в Российской Федерации. Сахарный диабет. 2014;7(1):4–7 [Lipatov D.V., Aleksandrova V.K., Atarshhikov D.S., Bessmertnaja E.G., Kon I.L., Kuz’min A.G., Smirnova N.B., Tolkacheva A.A., Chistjakov T.A. Current report from Russian Diabetic Retinopathy Register. Diabetes Mellitus = Saharnyj diabet. 2014;7(1):4–7 (In Russ.)]. DOI: 10.14341/DM201414-7

4. Дедов И.И., Шестакова М.В., Викулова О.К. Государственный регистр сахарного диабета в Российской Федерации: статус 2014 г. и перспективы развития. Сахарный диабет. 2015;18(3):5–22 [Dedov I.I., Shestakova M.V., Vikulova O.K. National register of diabetes mellitus in Russian Federation. Diabetes Mellitus = Saharnyj diabet. 2015;18(3):5–22 (In Russ.)]. DOI: 10.14341/DM201535-22

5. Woo J., Ng W., Salah M., Neelam K., Au Eong K., Kumar C. Perioperative glycaemic control in diabetic patients undergoing cataract surgery under local anaesthesia: a survey of practices of Singapore opthalmologists and anaesthesiologists. Singapore Med J. 2016;57(2):64–68. DOI: 10.11622/smedj.2016029

6. Pollreisz A., Schmidt-Erfurth U. Diabetic Cataract — Pathogenesis, Epidemiology and Treatment. J Ophthalmol. 2010;2010:1–8. DOI: 10.1155/2010/608751

7. Малюгин Б.Э. Хирургия катаракты и интраокулярная коррекция на современном этапе развития офтальмохирургии. Вестник офтальмологии. 2014;6:80–88 [Malyugin B.E. State-of-the-art cataract surgery and intraocular optical correction. Annals of Ophthalmology = Vestnik oftal’mologii. 2014;6:80–88 (In Russ.)].

8. Draganic V., Vukosavljevic M., Petrovic N., Milivojevic M., Resan M. Evolution of cataract surgery: smaller incision — less complications. Vojnosanit Pregl. 2012;69(5):385–388.

9. De Silva S.R., Riaz Y., Evans J.R. Phacoemulsification with posterior chamber intraocular lens versus extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens for age-related cataract. Cochrane Database Syst Rev. 2014;1:53. DOI: 10.1002/14651858.CD008812.pub2

10. Greenberg P.B., Tseng V.L., Wu W.C., Liu J., Jiang L., Chen C.K., Scott I.U., Friedmann P.D. Prevalence and predictors of ocular complications associated with cataract surgery in United States veterans. Ophthalmology. 2011;118(3):507–514. DOI: 10.1016/j.ophtha.2010.07.023

11. Irvine S.R. A newly defined vitreous syndrome following cataract surgery. Am J Ophthalmol. 1953;36(5):599–619.

12. Daien V., Papinaud L., Domerg C., Lacombe S., Daures J., Villain M. Incidence and Characteristics of Cystoid Macular Edema after Cataract Surgery. Ophthalmology. 2016;123(3):663–664. DOI: 10.1016/j.ophtha.2015.10.009

13. Grzybowski A., Sikorski B., Ascaso F., Huerva V. Pseudophakic cystoid macular edema: update 2016. Clin Interv Aging. 2016;11:1221–1229. DOI: 10.2147/CIA.S111761

14. Sahin M., Cingu A.K., Gozum N. Evaluation of Cystoid Macular Edema Using Optical Coherence Tomography and Fundus Autofluorescence after Uncomplicated Phacoemulsification Surgery. J Ophthalmol. 2013;2013:1–5. DOI: 10.1155/2013/376013

15. Tsilimbaris M.K., Tsika C., Diakonis V., Karavitaki A., Pallikaris I. Macular Edema and Cataract Surgery. Cataract Surgery. 2013;22:323–336. DOI: 10.5772/765

16. Eriksson U., Alm A., Bjarnhall G., Granstam E., Matsson A.W. Macular edema and visual outcome following cataract surgery in patients with diabetic retinopathy and controls. Graefes Arch Clin Exp Ophthalmol. 2011;249(3):349–359. DOI: 10.1007/s00417-010-1484-9

17. Baker C.W., Almukhtar T., Bressler N.M., Glassman A.R., Grover S., Kim S.J., Murtha T.J., Rauser M.E., Stockdale C. Diabetic Retinopathy Clinical Research Network. Macular edema after cataract surgery in eyes without preoperative centralinvolved diabetic macular edema. JAMA Ophthalmol. 2013;131(7):870–879. DOI: 10.1001/jamaophthalmol.2013.2313

18. Liu J., Jones R.E., Zhao J., Zhang J., Zhang F. Influence of uncomplicated phacoemulsification on central macular thickness in diabetic patients: a meta-analysis. PLoS One. 2015;10(5):e0126343. DOI: 10.1371/journal.pone.0126343

19. Yang J., Cai L., Sun Z., Ye H., Fan Q., Zhang K., Lu W., Lu Y. Risk factors for and diagnosis of pseudophakic cystoid macular edema after cataract surgery in diabetic patients. J Cataract Refract Surg. 2017;43(2):207–214. DOI: 10.1016/j.jcrs.2016.11.047

20. Reznicek L., Kernt M., Haritoglou C. Correlation of leaking microaneurysms with retinal thickening in diabetic retinopathy. Int J Ophthalmol. 2011;4(3):269–271. DOI: 10.3980/j.issn.2222-3959.2011.03.11

21. Худяков А.Ю., Сорокин Е.Л., Руденко В.А. Патогенетическая роль витреомакулярных тракций в формировании макулярного отека после факоэмульсификации катаракты. Дальневосточный медицинский журнал. 2011;3:72–75 [Khudyakov A.Yu., Sorokin E.L., Rudenko V.A. The peculiarities of vitreomacular interface and its role in pathogenesis of macular edema after phacoemulsification. Far East Medical Journal = Dal’nevostochnyj medicinskij zhurnal. 2011;3:72–75 (In Russ.)].

22. Law S., Kim E., Yu F., Caprioli J. Clinical Cystoid Macular Edema after Cataract Surgery in Glaucoma Patients. J Glaucoma. 2010;19(2):100–104. DOI: 10.1097/IJG.0b013e3181a98b97

23. Маннанова Р.Ф., Шевчук Н.Е., Бикбулатова А.А. Значение исследования цитокинов в хирургическом лечении катаракты. Точка зрения. Восток — Запад. 2017;3:113–116 [Mannanova R.F., Shevchuk N.E., Bikbulatova A.A. The value of the study of cytokines in cataract surgical treatment. Point of View. East — West = Tochka zrenija. Vostok — Zapad. 2017;3:113–116 (In Russ.)].

24. Созуракова Е.А., Громакина Е.В., Шабалдин А.В., Шахматов К.С. Результаты иммунологического исследования уровня цитокинов во влаге передней камеры и сыворотке крови при оперативном лечении катаракты. Точка зрения. Восток — Запад. 2017;3:33–36 [Sozurakova E.A., Gromakina E.V., Shabaldin A.V., Shakhmatov K.S. Immunology research results cytokine levels in anterior chamber aqueous humor and blood serum during surgical treatment of cataract. Point of View. East — West = Tochka zrenija. Vostok — Zapad. 2017;3:33–36 (In Russ.)].

25. Орадова А.Ш., Устенова Г.О., Стабаева Г.С.. Методы исследования цитокинов. MEDICINE. 2014;10:84–87 [Oradova A.Sh., Ustenova G.O., Stabaeva G.S.. Methods of cytokine research. MEDICINE. 2014;10:84–87 (In Russ.)].

26. Zhang Y., Birru R., Di Y.P. Analysis of clinical and biological samples using microsphere-based multiplexing Luminex system. Methods Mol Biol. 2014;1105:43–57. DOI: 10.1007/978-1-62703-739-6_4

27. Полетаев А.Б. Физиологическая иммунология (естественные аутоантитела и проблемы наномедицины). М.: Миклош, 2010. 218 с. [Poletaev A.B. Physiological immunology (natural autoantibodies and problems of nanomedicine). Moscow: Miklosh, 2010. 218 p. (In Russ.)].

28. Hartnett M.E., Tinkham N., Paynter L., Geisen P., Rosenberg P., Koch G., Cohen K.L. Aqueous vascular endothelial growth factor as a predictor of macular thickening following cataract surgery in patients with diabetes mellitus. Am J Ophthalmol. 2009;148(6):895–901. DOI: 10.1016/j.ajo.2009.07.014

29. Mitroviс S., Kelava T., Sucur A., Grcevic D. Levels of Selected Aqueous Humor Mediators (IL-10, IL-17, CCL2, VEGF, FasL) in Diabetic Cataract. Ocul Immunol Inflamm. 2016;24(2):159–166. DOI: 10.3109/09273948.2014.949779

30. Кузьмин А.Г., Липатов Д.В., Чистяков Т.А., Смирнова О.М., Арбузова М.И., Ильин А.В., Шестакова М.В. Сосудистый эндотелиальный фактор роста в жидкости передней камеры глаза у больных диабетической ретинопатией, катарактой и неоваскулярной глаукомой. Сахарный диабет. 2010;13(3):32–36 [Kuz’min A.G., Lipatov D.V., Chistyakova T.A., Smirnova O.M., Arbuzova M.I., Ilyin A.V., Shestakova M.V. Vascular endothelial growth factor in the fluid of the anterior chamber of the eye in patients with diabetic retinopathy, cataract and neovascular glaucoma. Diabetes Mellitus = Saharnyj diabet. 2010;13(3):32–36 (In Russ.)]. DOI: 10.14341/2072-0351-5485

31. Dong N., Xu B., Wang B., Chu L. Study of 27 aqueous humor cytokines in patients with type 2 diabetes with or without retinopathy. Mol Vis. 2013;19:1734–1746.

32. Dong N., Xu B., Chu L., Tang X. Study of 27 Aqueous Humor Cytokines in Type 2 Diabetic Patients with or without Macular Edema. PLoS One. 2015;10(4):e0125329. DOI: 10.1371/journal.pone.0125329

33. Cheung C.M, Vania M., Ang M., Chee S.P., Li J. Comparison of aqueous humor cytokine and chemokine levels in diabetic patients with and without retinopathy. Mol Vis. 2012;18:830–837.

34. Jonas J.B, Jonas R.A, Neumaier M., Findeisen P. Cytokine concentration in aqueous humor of eyes with diabetic macular edema. Retina. 2012;32(10):2150–2157. DOI: 10.1097/IAE.0b013e3182576d07

35. Hari-Kovacs A., Lovas P., Facsko A., Crate I.D. Is second eye phacoemulsification really more painful? Wien Klin Wochenschr. 2012;124:516–519. DOI: 10.1007/s00508-012-0205-2

36. Zhu X.J., Wolff D., Zhang K.K., He W.W., Sun X.H., Lu Y., Zhou P. Molecular Inflammation in the Contralateral Eye after Cataract Surgery in the First Eye. Invest Ophthalmol Vis Sci. 2015;56(9):5566–5573. DOI: 10.1167/iovs.15-16531

37. Weber K.S., Nelson P.J., Grone H.J., Weber C. Expression of CCR2 by endothelial cells: implications for MCP-1 mediated wound injury repair and In vivo inflammatory activation of endothelium. Arterioscler Thromb Vasc Biol. 1999;19:2085–2093.

38. Kawai M., Inoue T., Inatani M., Tsuboi N., Shobayashi K., Matsukawa A., Yoshida A., Tanihara H. Elevated levels of monocyte chemoattractant protein-1 in the aqueous humor after phacoemulsification. Invest Ophthalmol Vis Sci. 2012;53(13):7951–7960. DOI: 10.1167/iovs.12-10231

39. Zelova H., Hosek J. TNF-α signalling and inflammation: interactions between old acquaintances. Inflamm Res. 2013;62(7):641–651. DOI: 10.1007/s00011-013-0633-0

40. Chu L., Wang B., Xu B., Dong N. Aqueous cytokines as predictors of macular edema in non-diabetic patients following uncomplicated phacoemulsification cataract surgery. Mol Vis. 2013;19:2418–2425.

41. Dong N., Xu B., Wang B., Chu L., Tang X. Aqueous cytokines as predictors of macular edema in patients with diabetes following uncomplicated phacoemulsification cataract surgery. Biomed Res Int. 2015;2015:1–8. DOI: 10.1155/2015/126984

42. Palomo J., Dietrich D., Martin P., Palmer G., Gabay C. The interleukin (IL)-1 cytokine family-Balance between agonists and antagonists in inflammatory diseases. Cytokine. 2015;76(1):25–37. DOI: 10.1016/j.cyto.2015.06.017

43. Baptista F.I., Aveleira C.A., Castilho A.F., Ambrosio A.F. Elevated Glucose and Interleukin-1β Differentially Affect Retinal Microglial Cell Proliferation. Mediators Inflamm. 2017;2017:1–11. DOI: 10.1155/2017/4316316

44. Noma H. Vitreous inflammatory factors and serous macular detachment in branch retinal vein occlusion. Retina. 2012;32(1):86–91. DOI: 10.1097/IAE.0b013e31821801de

45. Koss M. J., Pfister M., Rothweiler F. Comparison of cytokine levels from undiluted vitreous of untreated patients with retinal vein occlusion. Acta Ophthalmol. 2012;90(2):98–103. DOI: 10.1111/j.1755-3768.2011.02292.x

46. Saravia M., Zeman L., Ingolotti M., Schlaen A. The VEGF paradox: Does diabetic retinopathy protect from age related macular degeneration? Med Hypotheses. 2017;109:156–161. DOI: 10.1016/j.mehy.2017.10.001

47. Ouyang W., Rutz S., Crellin N.K., Valdez P.A., Hymowitz S.G. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol. 2011;29:71–109. DOI: 10.1146/annurev-immunol-031210-101312

48. Endo N., Kato S., Haruyama K., Shoji M., Kitano S. Efficacy of bromfenac sodium ophthalmic solution in preventing cystoid macular oedema after cataract surgery in patients with diabetes. Acta Ophthalmol. 2010;88(8):896–900. DOI: 10.1111/j.1755-3768.2009.01582.x

49. Singh R., Alpern L., Jaffe G.J., Lehmann R.P., Lim J., Reiser H.J., Sall K., Walters T., Sager D. Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy. Clin Ophthalmol. 2012;6:1259–1269. DOI: 10.2147/OPTH.S31902

50. Wielders L.H.P., Schouten J.S.A.G., Nuijts R.M.M.A. Prevention of macular edema after cataract surgery. Curr Opin Ophthalmol. 2018;29(1):48–53. DOI: 10.1097/ICU.0000000000000436

51. Chew E.Y., Glassman A.R., Beck R.W., Bressler N.M., Fish G.E., Ferris F.L., Kinyoun J.L. Ocular Side Effects Associated with Peribulbar Injections of Triamcinolone Acetonide for Diabetic Macular Edema. Retina. 2011;31(2):284–289. DOI: 10.1097/IAE.0b013e3181f049a8

52. Zhang Y.P, Peng X.Y., Li Z.H., Chen F.H. Hyperglycemic effects of a periocular dexamethasone injection in diabetic patients after vitreoretinal surgery. Biomed Environ Sci. 2012;25(3):311–316. DOI: 10.3967/0895-3988.2012.03.009

53. Udaondo P., Garcia-Pous M., Garcia-Delpech S., Salom D., Diaz-Llopis M. Prophylaxis of macular edema with intravitreal ranibizumab in patients with diabetic retinopathy after cataract surgery: a pilot study. J Ophthalmol. 2011;2011:1–4. DOI: 10.1155/2011/159436

54. Chae J.B., Joe S.G., Yang S.J., Lee J.Y., Sung K.R., Kim J.Y., Kim J.G., Yoon Y.H. Effect of combined cataract surgery and ranibizumab injection in postoperative macular edema in nonproliferative diabetic retinopathy. Retina. 2014;34(1):149–156. DOI: 10.1097/IAE.0b013e3182979b9e

55. Pollack A., Staurenghi G., Sager D., Mukesh B., Reiser H., Singh R.P. Prospective randomised clinical trial to evaluate the safety and efficacy of nepafenac 0.1 % treatment for the prevention of macular oedema associated with cataract surgery in patients with diabetic retinopathy. Br J Ophthalmol. 2017;101(4):423–427. DOI: 10.1136/bjophthalmol-2016-308617

56. Sarfraz M.H., Haq R.I., Mehboob M.A. Effect of topical nepafenac in prevention of macular edema after cataract surgery in patients with non-proliferative diabetic retinopathy. Pak J Med Sci. 2017;33(1):210–214. DOI: 10.12669/pjms.331.11644